11 chapters across the catalog
Reuters reports that the U.S. military conducted a clandestine social media campaign to discredit Chinese COVID-19 vaccines in Central Asia. The operation involved spreading rumors that the Sinovac vaccine contained pork derivatives to alienate Muslim populations. This psychological operation was reportedly a response to Chinese disinformation blaming the U.S. for the pandemic's origin.
Global Booster Outlook, Australia, South Korea, EU Vaccine Pass
Countries like Australia and South Korea are accelerating their booster timelines as Omicron spreads globally. A reported hack of the EU vaccine pass website revealed database fields prepared for up to eight booster shots. Despite Omicron appearing to cause milder symptoms, international governments remain in lockstep, pushing for a third dose of Western vaccines.
Vice President Kamala Harris traveled to Vietnam to pledge 500 million vaccine doses, but her arrival was reportedly delayed. During this delay, China successfully delivered 2 million doses of the Sinovac vaccine to the Vietnamese government. The hosts frame this as a geopolitical struggle for influence through "vaccine diplomacy."
PBS aired a report questioning the efficacy of China's Sinovac vaccine, citing high death rates among vaccinated healthcare workers in Indonesia. The report promoted Pfizer and Moderna's mRNA technology as scientifically superior. The hosts suggest the segment serves as a marketing tool for Western pharmaceutical companies, noting the lack of transparency in WHO emergency use listings.
A first-hand account details the rigorous travel requirements for entering Indonesia, including a five-night forced quarantine and the use of the "e-HAC" health app. The report highlights the "Green Zones" in Bali where local workers are allegedly forced to receive the Chinese Sinovac vaccine to maintain their jobs in the tourism sector.
Brazil faces a worsening healthcare crisis as the P1 variant leads to increased hospitalizations among younger populations. President Jair Bolsonaro faces criticism for his handling of the pandemic as the country struggles to secure enough doses of the Sinovac and AstraZeneca vaccines.
Reports from medical professionals highlight "breakthrough" COVID-19 cases occurring in fully vaccinated individuals within two months of their shots. Meanwhile, the Chinese-developed CoronaVac (Sinovac) is being used extensively in Brazil and other nations, with some producers claiming it offers a more traditional and potentially safer alternative to mRNA platforms.
Global Vaccine Distrust in the Philippines and Pakistan
Doctors and the public in the Philippines and Pakistan express significant distrust toward Chinese-made vaccines like Sinovac and Sinopharm, citing concerns over shoddy quality and varying efficacy rates. Despite the distrust, these vaccines are often the only ones available due to donations from the Chinese government. In Pakistan, health ministers have resorted to threatening workers to ensure they receive the shots.
International COVID-19 Reports from South Korea and China
Reports from South Korea indicate public anger over vaccine shortages and a 9 p.m. curfew for businesses. In China, faculty members at universities are being encouraged to "volunteer" for vaccines from Sinovac and Sinopharm. These vaccines utilize traditional adjuvants rather than mRNA technology, and there is skepticism among expatriates regarding the potential for travel exemptions post-vaccination.
China's CNBG and Sinovac are conducting Phase 3 vaccine trials in over ten countries, including Brazil, the UAE, and Peru, with plans to produce up to one billion doses annually. Meanwhile, Russia continues to promote its Sputnik V vaccine despite international skepticism regarding the speed of its approval. China has already authorized emergency use for high-risk groups like medical workers before the completion of final trials.
The World Health Organization has announced that China's drug safety authority now meets international standards, paving the way for Chinese firms like Sinovac to export vaccines globally. Sinovac is currently testing a vaccine for hand, foot, and mouth disease. The hosts express skepticism regarding the quality and legal accountability of Chinese-made medical products.
